COMP_VERDICT: clean_with_limitations
REVIEWED_SNAPSHOT: 44f3245b2b142c0131410aa75210c3ae21c6aa61ddd621555d23a38abf94670d
PROPAGATION_ELIGIBILITY: eligible_with_warning
SYNTHESIS_ELIGIBILITY: eligible_with_warning
ACTION_REQUIRED: no
PROPAGATION_ALLOWED_SCOPE: propagate only the bounded method-map result: concentration alone is insufficient; qualified product fate and calibrated capacity are required; source/boundary fate is required for declared ledger/systemic attribution
SYNTHESIS_ALLOWED_SCOPE: use as a structural-identifiability and measurement-contract constraint for luminal UOX only, with biological regime not evaluated
FORBIDDEN_INFERENCES: human dose; serum-urate effect; production sufficiency; topology/chassis ranking; assay validation; practical identifiability; safety/peroxide clearance; clinical advice; H08 closure

# Independent comp review — comp-050

## Reviewed snapshot
Reviewer: independent daemon consolidator for comp-050. Bound to daemon manifest SHA-256 `44f3245b2b142c0131410aa75210c3ae21c6aa61ddd621555d23a38abf94670d` at source commit `7505dc5e5d03c29d71e9e8acc4f75ec7038b5a5a`. Shard auditors reported complete text coverage of the push manifest; I reopened load-bearing code, contract, outputs summary, results, interpretive page, registry, H08, gut-lumen, uricase, open-questions, and prior authoring receipts for targeted cross-checks. The authoring gates are modern and valid; no deterministic binary block was reported.

## Bottom-line verdict
**Clean with limitations.** COMP-050 is a valid deterministic method map: it derives a conditional dimensionless capacity identity, demonstrates concentration-only non-identifiability, and audits structural identifiability under declared ideal observations. It remains strictly pre-biological: no human operating regime, assay validation, dose, serum effect, topology/chassis choice, peroxide safety, or H08 survival increment follows.

## Implementation and constraint closure
The computation fits the stated question. The code uses exact `Fraction` arithmetic for the response surface, counterexample balances, and row-space/rank tests. The conditional capacity equation follows from fixed substrate occupancy and calibrated active-capacity time area:
`Vmax_initial/J_total_mean = q/(occupancy × A_time)`, where `J_total_mean` is total local influx, not systemic-origin influx. This avoids the prior hidden substitution of enzyme capacity for physiological reaction rate, provided readers preserve the fixed-occupancy and measured-capacity assumptions.

The contract-to-code trace is closed: the ten unknowns, mass-balance signs, cumulative measurement combinations, conditional product observations, target vectors, failed-product branch, and output statuses are implemented in `analyze.py` and reported in JSON/CSV/summary. Product prerequisites are guarded as an exact eight-item set. When product observations are removed, local UOX removal and systemic-origin UOX removal become non-identifiable; non-product quantities that remain directly observed are labeled separately and do not rescue UOX attribution.

Constraint closure is intentionally limited. Reaction substrate, oxygen, localization, matrix recovery, residence time, active-enzyme time course, replenishment, reabsorption, outflow, product degradation/scavenging, peroxide burden, epithelial injury, and systemic compensation are not modeled as biological parameters. They are either prerequisites for an ideal observation or assigned to later validation, especially §1.33 and §1.36. This is acceptable because the artifact repeatedly states `biological_regime: NOT_EVALUATED`.

## Summary-fidelity audit
The generated summary, results JSON, focused interpretive page, `wiki/computational-experiments.md`, H08, gut-lumen sink, uricase, open questions, validation §1.33, multihop program, cross-validation, action guide, and graph surfaces are materially consistent. They preserve:
- concentration alone cannot identify local UOX removal;
- qualified product fate is load-bearing and ideal only;
- calibrated reaction-site capacity is separate from abundance or oxygen proxy;
- source influxes, boundary fates, and source-resolved product fate are required for systemic-origin attribution and declared ledger reconstructibility;
- practical ledger closure still requires a prespecified residual tolerance;
- H08 remains open with survival_count 0.

No inspected surface upgrades grid extrema `101/400` and `1010` into physiological estimates or planning values. No inspected surface claims global minimality, dose, serum effect, assay validation, topology winner, production sufficiency, or safety clearance.

## Reader-facing ownership audit
The focused computational page owns the method result and limitations. Mechanism pages carry compact consequences; portfolio and index pages route the result without turning it into a cross-track rank. Validation §1.33 uses the method map to specify measurement requirements, not to certify an assay. No personalized treatment instruction, narrative foil, phase-history residue, or duplicated long exposition requiring correction was found.

## Conjecture preservation audit
COMP-050 kills only the exact inference that luminal urate concentration or an unqualified product signal can identify local UOX removal in the declared formal setting. It does not kill luminal UOX as a route, any sequence/host/topology, ABCG2 genotype stratification as a future design variable, UOX/PDB staging, or the possibility of a future qualified product-fate assay. Those remain conjectures or open hypotheses gated on exact-configuration activity, product qualification, source/boundary fate, practical precision, redox safety, and translation.

## Generated-output and proposed-update inventory
| Path | Manifest kind | Inspected completely? | Finding |
|---|---|---|---|
| `wiki/etc/experiments/comp-050-luminal-uox-break-even-identifiability/outputs/break-even-surface.csv` | generated_output | Yes | 120-row conditional dimensionless surface; bounded as non-physiological grid. |
| `wiki/etc/experiments/comp-050-luminal-uox-break-even-identifiability/outputs/measurement-identifiability.csv` | generated_output | Yes | 48 rank/status rows; ideal and failed-product branches consistent. |
| `wiki/etc/experiments/comp-050-luminal-uox-break-even-identifiability/outputs/results.json` | generated_output | Yes | Complete definitions, matrices, statuses, checks, limitations; biological regime not evaluated. |
| `wiki/etc/experiments/comp-050-luminal-uox-break-even-identifiability/outputs/same-concentration-counterexamples.csv` | generated_output | Yes | Three exact steady-state parameterizations show different UOX flux at same concentration. |
| `wiki/etc/experiments/comp-050-luminal-uox-break-even-identifiability/outputs/summary.md` | generated_output | Yes | Faithful, bounded summary. |
| `wiki/luminal-uox-break-even-identifiability-computational.md` | proposed_update | Yes | Correct focused owner page; no overclaim. |
| `wiki/computational-experiments.md` | proposed_update | Yes | Registry entry bounded to method map. |
| `wiki/hypotheses/H08-gut-lumen-sink-platform-thesis.md` | proposed_update | Yes | H08 remains open; no survival/status upgrade. |
| `wiki/validation-experiments.md` | proposed_update | Yes | §1.33 and later UOX gates use COMP-050 as measurement boundary only. |
| `wiki/gut-lumen-sink.md` | proposed_update | Yes | Mechanism page consistent; retains physiological and safety gates. |
| `wiki/uricase.md` | proposed_update | Yes | Route and peroxide boundaries preserved. |
| `wiki/open-questions.md` | proposed_update | Yes | UOX questions remain unresolved; no genotype/dose inference. |
| `wiki/gout-multihop-research-program.md` | proposed_update | Yes | Sequencing keeps comp-050 ledger inputs before dynamic modeling. |
| `wiki/cross-validation.md` | proposed_update | Yes | Threat-model entry only; no feasibility score. |
| `wiki/etc/GRAPH.md` | proposed_update | Yes | Graph edge semantics correctly bounded. |
| `wiki/gout-action-guide.md` | proposed_update | Yes | No clinical-decision propagation. |
| `index.md` | proposed_update | Yes | Link/routing surface only; downstream support checked against authoring receipts. |

## Load-bearing verification table
| Claim or parameter | Artifact location | Implementation use | Provenance status | Verdict |
|---|---|---|---|---|
| `Vmax_initial/J_total_mean = q/(occupancy × A_time)` | README, code, summary, focused page | Direct response-surface formula | Formal derivation only, no biological source | Valid within fixed-occupancy assumptions. |
| `J_total_mean = (I_systemic + I_other)/T` | README/results | Denominator for capacity multiple | Defined in contract | Correctly total-local, not systemic-origin. |
| Surface extrema `101/400`, `1010` | results/focused page | Grid min/max | Derived from declared grid | Valid as grid boundaries only. |
| Same concentration can hide UOX flux `1/10`, `1/2`, `9/10` | counterexample CSV/results | Non-identifiability demonstration | Constructed formal scenarios | Valid mathematical counterexample, not patient model. |
| Product-equivalent observation prerequisites | model contract/results/focused page | Conditional observation guard and failed-product branch | Internal formal prerequisite set; assay not verified | Correctly load-bearing and not empirically established. |
| Local UOX removal identifiable with initial/terminal urate + qualified product | CSV/results/summary | Row-space target status | Exact linear model | Valid only under ideal qualified observation. |
| Ledger closure with full source/boundary/product observations | CSV/results/pages | Grouped target status | Exact linear model | Structural reconstructibility only; practical residual tolerance still required. |
| Biological regime `NOT_EVALUATED` | results/summary/wiki pages | Scope limiter | Artifact verdict | Correct and essential. |
| CPython 3.11 stdlib deterministic command | README/analyze.py | Reproduction path | Code inspection and prior post-run receipt; not daemon-executed | Plausible deterministic path. |

## Affected wiki pages
- `wiki/luminal-uox-break-even-identifiability-computational.md` — already consistent — owns bounded COMP-050 result.
- `wiki/computational-experiments.md` — already consistent — registry preserves method-map scope.
- `wiki/validation-experiments.md` — already consistent — §1.33/§1.36 gating retains local-performance and safety boundaries.
- `wiki/hypotheses/H08-gut-lumen-sink-platform-thesis.md` — already consistent — H08 open; dynamic model blocked on measured inputs.
- `wiki/gut-lumen-sink.md` — already consistent — no dose/effect/topology upgrade.
- `wiki/uricase.md` — already consistent — product fate, capacity, and peroxide gates preserved.
- `wiki/open-questions.md` — already consistent — unresolved UOX/genotype/co-engineering questions remain conjectural.
- `wiki/gout-multihop-research-program.md` — already consistent — sequencing requires exact configuration and ledger inputs.
- `wiki/cross-validation.md` — already consistent — threat-model map only.
- `wiki/etc/GRAPH.md` — already consistent — deterministic identifiability edge only.
- `wiki/gout-action-guide.md` — already consistent — no patient-facing recommendation.
- `wiki/supplements-stack.md`, `wiki/genotype-informed-supplement-workflow.md`, `wiki/gout-pathophysiology.md` — already consistent in targeted checks — luminal UOX remains unresolved/mechanistic extrapolation where mentioned.

## New connections or implications
COMP-050 sharpens a cross-corpus assay rule: any future §1.33, genotype-stratified UOX, co-engineered ABCG2-supply, or UOX/PDB-staging experiment that measures only urate concentration cannot attribute UOX removal. A grounded Research Conjecture that survives is: qualified source-resolved product fate may distinguish whether luminal UOX consumes systemic-origin urate versus other local urate, but the unsupported leap is that such measured local capture will translate to serum urate; the discriminating observation is paired source-resolved product fate plus complete boundary-fate ledger and later systemic urate handling.

## Required actions
1. None.

## Review limits
Daemon review did not execute code or independently retrieve primary literature. CSV completeness and full `validation-experiments.md` coverage rely on hash-bound shard audits, with targeted repository reopening for load-bearing files. Primary-source claims on ALLN-346, PULSE, terminal-ileal urate, and assay methods were not reverified here and should not be treated as newly primary-validated by this receipt.
